These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8149879)

  • 1. Drug concentrations in human brain tissue samples from epileptic patients treated with felbamate.
    Adusumalli VE; Wichmann JK; Kucharczyk N; Kamin M; Sofia RD; French J; Sperling M; Bourgeois B; Devinsky O; Dreifuss FE
    Drug Metab Dispos; 1994; 22(1):168-70. PubMed ID: 8149879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic drug monitoring of felbamate].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal administration of felbamate in a child with Lennox-Gastaut syndrome.
    Grossmann R; Maytal J; Fernando J
    Neurology; 1994 Oct; 44(10):1979. PubMed ID: 7936261
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of felbamate in therapy for partial epilepsy in children.
    Carmant L; Holmes GL; Sawyer S; Rifai N; Anderson J; Mikati MA
    J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy.
    Sachdeo RC; Narang-Sachdeo S; Montgomery PA; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    J Clin Pharmacol; 1998 Feb; 38(2):184-90. PubMed ID: 9549651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for use of felbamate in adult, adolescent, and child inpatients and outpatients.
    Luer MS
    Am J Hosp Pharm; 1994 Jul; 51(13):1701-3; Quiz 1704-5. PubMed ID: 7942896
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous determination of felbamate and three metabolites in human plasma by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    Ther Drug Monit; 1994 Feb; 16(1):83-9. PubMed ID: 8160261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction studies between felbamate and vigabatrin.
    Reidenberg P; Glue P; Banfield C; Colucci R; Meehan J; Rey E; Radwanski E; Nomeir A; Lim J; Lin C
    Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary mania associated with the use of felbamate.
    Hill RR; Stagno SJ; Tesar GE
    Psychosomatics; 1995; 36(4):404-6. PubMed ID: 7652143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and sensitive LC-MS/MS method for determination of felbamate in mouse plasma and tissues and human plasma.
    Hansen RJ; Samber BJ; Gustafson DL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3432-6. PubMed ID: 21081288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felbamate.
    Sofia RD; Kramer L; Perhach JL; Rosenberg A
    Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
    Steinhoff BJ
    Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antiepileptic drugs: vagabatrin, lamotrigine and felbamate].
    Herranz JL; Arteaga R; Armijo JA
    Neurologia; 1994 Nov; 9(9):410-7. PubMed ID: 7811493
    [No Abstract]   [Full Text] [Related]  

  • 17. Involuntary movement disorders associated with felbamate.
    Kerrick JM; Kelley BJ; Maister BH; Graves NM; Leppik IE
    Neurology; 1995 Jan; 45(1):185-7. PubMed ID: 7824115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of felbamate and three metabolites in rat and dog plasmas by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    J Chromatogr; 1993 Dec; 622(2):229-34. PubMed ID: 8150870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the anticonvulsant felbamate and its three metabolites in brain and heart tissue of rats.
    Jacala A; Adusumalli VE; Kucharczyk N; Sofia RD
    J Chromatogr; 1993 May; 614(2):285-92. PubMed ID: 8314941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.
    Potschka H; Fedrowitz M; Löscher W
    Neurosci Lett; 2002 Jul; 327(3):173-6. PubMed ID: 12113905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.